Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
CVS Health Corp(CVS)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for CVS
10/13/2026: CVS (2-star) is currently NOT-A-BUY. Pass it for now.
CVS Health is a vertically integrated healthcare company operating across pharmacy services, benefit management, and insurance. The company benefits from its massive retail footprint and deep integration into the healthcare value chain, which provides defensive characteristics. Its growth story hinges on successfully expanding primary care delivery through recent acquisitions to better serve the aging Medicare population. However, the company faces significant risks from increasing drug pricing regulation and high levels of debt from past deals. The stock may appeal to value-oriented and dividend-seeking investors who can look past near-term regulatory and integration headwinds to focus on the company's long-term competitive positioning.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | While the company seeks new growth in primary care, the core segments are mature and face competitive pressures. |
| Momentum investor | Weak fit | The stock has experienced significant volatility and is not currently exhibiting a strong uptrend signal. |
| Value investor | Strong fit | The stock often trades at a valuation multiple that may appear attractive to value-oriented investors relative to its scale. |
| Dividend investor | Strong fit | CVS has a history of reliable dividend payments that appeal to those seeking regular income. |
| Low-risk investor | Mixed fit | Healthcare regulatory and execution risks add a layer of uncertainty that may not suit the most conservative investors. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium / high | The stock is sensitive to policy changes and shifts in healthcare utilization trends. |
| Valuation risk | Medium | Market sentiment regarding healthcare reform can lead to periods of multiple compression. |
| Competition risk (healthcare consolidation) | High | Aggressive moves by major insurers and tech entrants challenge existing profit margins. |
| Business quality | Strong | The company has an expansive, defensive business model with deep entrenchment in the healthcare system. |
| Dividend income | Medium | While consistent, dividend growth depends on the stability of cash flows amid regulatory pressures. |
| Execution risk | Medium / high | Integrating diverse, multi-billion dollar acquisitions like Oak Street Health is operationally complex. |
Price Behavior
Rolling Over
The price momentum is slowing down and beginning to turn downward.
Moderately Choppy
The stock has experienced noticeable price swings while retaining some directional structure.
Analysis of Past Performance
Type Stock | Historic Profit -5.28% | Avg. Invested days 36 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/13/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 112.22B USD | Price to earnings Ratio 23.52 | 1Y Target Price 115.48 |
Price to earnings Ratio 23.52 | 1Y Target Price 115.48 | ||
Volume (30-day avg) 8.4M shares | Beta 0.6 | 52 Weeks Range 68.48 - 110.00 | Updated Date 10/13/2026 |
52 Weeks Range 68.48 - 110.00 | Updated Date 10/13/2026 | ||
Dividends yield (FY) 3.09% | Basic EPS (TTM) 3.73 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Health Care Benefits | Health insurance plans including Medicare and Medicaid managed care. | The company collects premiums from insurance members and pays for their medical care. |
| Health Services | Pharmacy benefit management (PBM) and specialty pharmacy services. | The company manages drug formularies and costs for large employers and health plans. |
| Pharmacy & Consumer Wellness | Retail pharmacy operations and health products. | The company makes money from filling prescriptions and selling consumer health goods. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Valuation
Trailing PE 23.52 | Forward PE 10.67 | Enterprise Value 172.16B | Price to Sales(TTM) 0.27 |
Enterprise Value 172.16B | Price to Sales(TTM) 0.27 | ||
Enterprise Value to Revenue 0.43 | Enterprise Value to EBITDA 13.26 | Shares Outstanding 1.28B | Shares Floating 1.28B |
Shares Outstanding 1.28B | Shares Floating 1.28B | ||
Percent Insiders 0.06 | Percent Institutions 90.86 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.